Precision Medicine

TRexBio has dosed the first patient in a new trial for its novel drug, TRB-061, which aims to rebalance the immune system to treat atopic dermatitis.

Imviva Biotech's new CAR-T therapy shows potential for durable remission in lupus, moving advanced cell treatments beyond cancer to autoimmune disease.

With patient enrollment accelerating for its novel lung fibrosis drug, LTI-03, Rein Therapeutics signals progress in a field desperate for new options.

A new FDA-cleared system from Chest Wall Innovations offers both PEEK and titanium implants, promising surgeons unprecedented versatility in treating rib fractures.

A new partnership brings mask-free sleep apnea therapy to veterans, aligning with updated DoD/VA guidelines that prioritize patient preference and comfort.

Genomics' big data and Greywolf's novel drugs unite to develop first-in-class treatments for autoimmune diseases, promising a new era of precision medicine.

A landmark study reveals a hidden genetic cause for a common kidney disease in adults, urging for expanded genetic screening and paving the way for new therapies.

A new interactive lab and large-scale survey aim to combat pervasive gum disease. How does this data-driven approach fit into Hong Kong's public health landscape?

With financials improving but competition rising, medical device maker Pulmonx faces a critical audience at the BofA healthcare conference in May.

A new HHS agenda reopens the door for controversial peptides, just as a wave of next-gen obesity drugs threatens to upend the entire market.

A new therapy programs immune cells inside the body to fight disease. Sail Biomedicines is pioneering this approach to offer a potential cure for autoimmunity.

A new grant from Zymo Research aims to solve a key data problem in gut science, potentially unlocking the next wave of breakthroughs in personalized medicine.

A new report reveals payers are rewriting drug benefit rules, sacrificing rebates for more control as they grapple with the high cost of new therapies.

A new partnership brings a single-dose treatment for common, serious infections to Sub-Saharan Africa, a region with high prevalence and unmet medical needs.

A landmark study reveals essential phospholipids significantly reduce liver fat and fatigue in MASLD patients, offering a new tool against a silent epidemic.

By emphasizing deep anatomical knowledge, Medytox aims to elevate industry standards and solidify its leadership in Asia's booming medical aesthetics market.

Top expert Dr. Henrik Zetterberg joins Circular Genomics, signaling a pivotal shift toward novel circular RNA blood tests for neurodegenerative disease.

A revolutionary organ preservation system is showing 100% graft survival in new studies, promising to expand the donor pool for children in need.

Millions are using GLP-1 drugs for weight loss, but an unexpected side effect is emerging: a prominent 'buffalo hump' that surgery is now targeting.

A new study reveals that poor muscle quality, measured by advanced MRI, is a powerful predictor of death in CKD patients, shifting focus to systemic health.